DOI QR코드

DOI QR Code

Neonatal Patent Ductus Arteriosus Ligation Operations Performed by Adult Cardiac Surgeons

  • Chung, Yoon Sang (Department of Thoracic and Cardiovascular Surgery, Chung-Ang University Hospital) ;
  • Cho, Dai Yun (Department of Thoracic and Cardiovascular Surgery, Chung-Ang University Hospital) ;
  • Kang, Hyun (Department of Anesthesiology and Pain Medicine, Chung-Ang University Hospital) ;
  • Lee, Na Mi (Department of Pediatrics, Chung-Ang University Hospital) ;
  • Hong, Joonhwa (Department of Thoracic and Cardiovascular Surgery, Chung-Ang University Hospital)
  • Received : 2016.12.01
  • Accepted : 2017.04.19
  • Published : 2017.08.05

Abstract

Background: Patent ductus arteriosus (PDA) ligation is usually performed by congenital cardiac surgeons. However, due to the uneven distribution of congenital cardiac surgeons in South Korea, many institutions depend solely on adult cardiac surgeons for congenital cardiac diseases. We report the outcomes of PDA ligations performed by adult cardiac surgeons at our institution. Methods: The electronic medical records of 852 neonates at Chung-Ang University Hospital, Seoul, South Korea from November 2010 to May 2014 were reviewed to identify patients with PDA. Results: Of the 111 neonates with a diagnosis of PDA, 26 (23%) underwent PDA ligation. PDAs were ligated within 28 days of birth (mean, $14.5{\pm}7.8days$), and the mean gestational age of these patients was $30.3{\pm}4.6weeks$ (range, 26 to 40 weeks) with a mean birth weight of $1,292.5{\pm}703.5g$ (range, 480 to 3,020 g). No residual shunts through the PDA were found on postoperative echocardiography. There was 1 case of 30-day mortality (3.8%) due to pneumonia, and 6 cases of in-hospital mortality (23.1%) after 30 days, which is comparable to results from other centers with congenital cardiac surgery programs. Conclusion: Although our outcomes may not be generalizable to all hospital settings without a congenital cardiac surgery program, in select centers, PDA ligations can be performed safely by adult cardiac surgeons if no congenital cardiac surgery program is available.

Keywords

References

  1. Kitterman JA, Edmunds LH Jr, Gregory GA, Heymann MA, Tooley WH, Rudolph AM. Patent ducts arteriosus in premature infants: incidence, relation to pulmonary disease and management. N Engl J Med 1972;287:473-7. https://doi.org/10.1056/NEJM197209072871001
  2. Hoffman JI, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol 2002;39:1890-900. https://doi.org/10.1016/S0735-1097(02)01886-7
  3. Clyman RI. Ibuprofen and patent ductus arteriosus. N Engl J Med 2000;343:728-30. https://doi.org/10.1056/NEJM200009073431009
  4. Lee JA, Kim MJ, Oh S, Choi BM. Current status of therapeutic strategies for patent ductus arteriosus in verylow-birth-weight infants in Korea. J Korean Med Sci 2015;30 Suppl 1:S59-66. https://doi.org/10.3346/jkms.2015.30.S1.S59
  5. Alan S, Karadeniz C, Okulu E, et al. Management of patent ductus arteriosus in preterm infants: clinical judgment might be a fair option. J Matern Fetal Neonatal Med 2013;26:1850-4. https://doi.org/10.3109/14767058.2013.801956
  6. Jang SH, Kim JH, Yeom JS, et al. Incidence of congenital heart disease in the western part of Gyeongnam Province in Korea. Korean J Pediatr 2008;51:848-55. https://doi.org/10.3345/kjp.2008.51.8.848
  7. Lee JH, Shim GH, Shin KS, et al. Congenital heart disease in Jeju: postnatal incidence and clinical features. Korean J Pediatr 2004;47:294-303.
  8. Lee KS, Kim CS, Park JH, et al. The longitudinal trend of cardiac surgery in Korea from 2003 to 2013. Korean J Thorac Cardiovasc Surg 2016;49(Suppl 1):S1-S13.
  9. Lee JE, Jung KL, Kim SE, et al. Prenatal diagnosis of congenital heart disease: trends in pregnancy termination rate, and perinatal and 1-year infant mortalities in Korea between 1994 and 2005. J Obstet Gynaecol Res 2010;36:474-8. https://doi.org/10.1111/j.1447-0756.2010.01222.x
  10. Lee LC, Tillett A, Tulloh R, Yates R, Kelsall W. Outcome following patent ductus arteriosus ligation in premature infants: a retrospective cohort analysis. BMC Pediatr 2006;6:15. https://doi.org/10.1186/1471-2431-6-15
  11. Raval MV, Laughon MM, Bose CL, Phillips JD. Patent ductus arteriosus ligation in premature infants: who really benefits, and at what cost? J Pediatr Surg 2007;42:69-75. https://doi.org/10.1016/j.jpedsurg.2006.09.040
  12. Lee GY, Sohn YB, Kim MJ, et al. Outcome following surgical closure of patent ductus arteriosus in very low birth weight infants in neonatal intensive care unit. Yonsei Med J 2008;49:265-71. https://doi.org/10.3349/ymj.2008.49.2.265
  13. Jaillard S, Larrue B, Rakza T, Magnenant E, Warembourg H, Storme L. Consequences of delayed surgical closure of patent ductus arteriosus in very premature infants. Ann Thorac Surg 2006;81:231-4. https://doi.org/10.1016/j.athoracsur.2005.03.141
  14. Gould DS, Montenegro LM, Gaynor JW, et al. A comparison of on-site and off-site patent ductus arteriosus ligation in premature infants. Pediatrics 2003;112(6 Pt 1):1298-301. https://doi.org/10.1542/peds.112.6.1298
  15. Markush D, Briden KE, Chung M, et al. Effect of surgical subspecialty training on patent ductus arteriosus ligation outcomes. Pediatr Surg Int 2014;30:503-9. https://doi.org/10.1007/s00383-014-3469-y

Cited by

  1. Surgical management of a patent ductus arteriosus: Is this still an option? vol.23, pp.4, 2017, https://doi.org/10.1016/j.siny.2018.03.003